Literature DB >> 16899858

Diffuse alveolar damage: uncommon manifestation of pulmonary involvement in patients with connective tissue diseases.

Joseph G Parambil1, Jeffrey L Myers, Jay H Ryu.   

Abstract

BACKGROUND: Diffuse alveolar damage (DAD) is a relatively common finding on surgical lung biopsy and can result from a variety of causes.
METHODS: We studied nine consecutive patients with connective tissue disease (CTD) and DAD diagnosed on surgical lung biopsy to examine this association and clinical implications.
RESULTS: The median age was 63 years (range, 35 to 76 years), and seven of the patients were women (78%). Underlying CTDs included rheumatoid arthritis in five patients, polymyositis in two patients, and one patient each with systemic sclerosis and mixed CTD. In seven patients (78%), CTD had been diagnosed before the onset of DAD; six of these patients had a preexisting interstitial lung disease (ILD) related to their CTD. DAD was the presenting manifestation leading to a new CTD diagnosis in two patients (22%). CT of the chest revealed ground-glass opacities and/or consolidation bilaterally with or without honeycombing. In all patients, surgical lung biopsy revealed DAD for which no cause could be identified other than the underlying CTD. Seven patients (78%) were receiving mechanical ventilatory support at the time of the surgical lung biopsy. Four patients (44%) survived to hospital discharge and included one patient with preexisting ILD and all three patients without chronic ILD.
CONCLUSION: We conclude that DAD can complicate the clinical course of patients with CTD-related chronic ILD, or can occasionally occur as a presenting manifestation of CTDs. When DAD occurs in patients with CTDs, the outcome appears to be worse for those with preexisting chronic ILD compared to those without ILD.

Entities:  

Mesh:

Year:  2006        PMID: 16899858     DOI: 10.1378/chest.130.2.553

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

Review 1.  Management of interstitial lung disease associated with connective tissue disease.

Authors:  Stephen C Mathai; Sonye K Danoff
Journal:  BMJ       Date:  2016-02-24

2.  Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: a prospective study and review of the literature.

Authors:  Andreina Manfredi; Marco Sebastiani; Stefania Cerri; Caterina Vacchi; Roberto Tonelli; Giovanni Della Casa; Giulia Cassone; Amelia Spinella; Pancaldi Fabrizio; Fabrizio Luppi; Carlo Salvarani
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

Review 3.  Procyanidins and Their Therapeutic Potential against Oral Diseases.

Authors:  Huan Chen; Wanyu Wang; Shiyang Yu; Huimin Wang; Zilu Tian; Song Zhu
Journal:  Molecules       Date:  2022-05-04       Impact factor: 4.927

Review 4.  A roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung disease.

Authors:  Tracy J Doyle; Joyce S Lee; Paul F Dellaripa; James A Lederer; Eric L Matteson; Aryeh Fischer; Dana P Ascherman; Marilyn K Glassberg; Jay H Ryu; Sonye K Danoff; Kevin K Brown; Harold R Collard; Ivan O Rosas
Journal:  Chest       Date:  2014-03-01       Impact factor: 9.410

5.  MiR-15a/16 Regulates Apoptosis of Lung Epithelial Cells after Oxidative Stress.

Authors:  Yong Cao; Duo Zhang; Hyung-Geun Moon; Heedoo Lee; Jeffrey A Haspel; Kebin Hu; Lixin Xie; Yang Jin
Journal:  Mol Med       Date:  2016-04-27       Impact factor: 6.354

6.  A systematic review of the incidence, risk factors and prognosis of acute exacerbation of systemic autoimmune disease-associated interstitial lung disease.

Authors:  Hiroyuki Kamiya; Ogee Mer Panlaqui
Journal:  BMC Pulm Med       Date:  2021-05-05       Impact factor: 3.317

Review 7.  Current concepts and dilemmas in idiopathic interstitial pneumonias.

Authors:  Jay H Ryu; Teng Moua; Natalya Azadeh; Misbah Baqir; Eunhee S Yi
Journal:  F1000Res       Date:  2016-11-10

8.  A case of delayed exacerbation of interstitial lung disease after discontinuation of temsirolimus.

Authors:  Rei Matsuki; Kenichi Okuda; Akihisa Mitani; Yasuhiro Yamauchi; Goh Tanaka; Haruki Kume; Yukio Homma; Munetoshi Hinata; Akimasa Hayashi; Junji Shibahara; Masashi Fukayama; Takahide Nagase
Journal:  Respir Med Case Rep       Date:  2017-08-11

Review 9.  Diffuse alveolar damage in a patient with rheumatoid arthritis under prolonged leflunomide treatment: A Case Report and Literature Review.

Authors:  Li-Ta Keng; Mong-Wei Lin; Hsien-Neng Huang; Kuei-Pin Chung
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

10.  Pulmonary involvement in rheumatoid arthritis: A cross-sectional study in Iran.

Authors:  Habib Zayeni; Asghar Haji-Abbasi; Seyed Ali Alavi Foumani; Mehdi Tohidi; Irandokht Shenavar Masooleh; Banafsheh Ghavidel Parsa; Mehrdad Aghaei; Amir Hassankhani; Pooneh Ghavidel Parsa; Alireza Amir Maafi
Journal:  Lung India       Date:  2016 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.